|
Socio-demographic variables
| | | |
|
Maternal age [mean ± SD]
|
25.3 ± 4.7
|
27.3 ± 4.9
|
< 0.0001
|
|
Primipara [N (%)]
|
5 (12)
|
0 (0)
|
/
|
|
HIV-related factors at enrolment
| | | |
|
HIV viral load [median copies per ml (IQR)]
|
30,412 (6,864; 80,557)
|
18,918 (7,162; 78,152)
|
0.34
|
|
CD4 cells per μl [median (IQR)]
|
430 (303, 595)
|
334 (188, 460)
|
< 0.0001
|
|
Disease stage III [N (%)]
|
14 (33)
|
9 (21)
|
0.30
|
|
BMI at 1 month post partum [mean ± SD]
|
21.4 ± 2.8
|
22.4 ± 3.1
|
0.007
|
|
Hemoglobin [g/dl] [mean ± SD]
|
10.7 ± 1.5
|
11.0 ± 1.4
|
0.24
|
|
Positive rapid plasma regain test for syphilis [N (%)]
|
9 (22)
|
5 (12)
|
0.22
|
|
Obstetric and infant variables
| | | |
|
Caesarean sections [N (%)]
|
2 (5)
|
0 (0)
|
/
|
|
Low birth weight [N (%) < 2500 g]
|
5 (12)
|
2 (5)
|
0.45
|
|
Birth weight [mean ± SD]
|
3029 ± 536
|
3042 ± 469
|
0.82
|
|
Preterm delivery [N (%) ≤ 34 weeks of gestation]
|
5 (12)
|
8 (19)
|
0.75
|
|
Sex [N (%) male]
|
23 (53)
|
16 (37)
|
0.14
|
|
Nevirapine prophylaxis at current delivery
| | | |
|
Maternal dose taken [N (%)]
|
43 (100)
|
43 (100)
|
/
|
|
Infant dose taken [N (%)]
|
40 (93)
|
41 (98)
|
1.0
|
|
HIV transmission and infant mortality
| | | |
|
Infants HIV positive ≤ day 42 [N (%)]
|
3 (7)
|
3 (7)
|
1.0
|
|
Infants HIV positive or died ≤ day 42 [N (%)]
|
4 (9)
|
3 (7)
|
1.0
|
